» Articles » PMID: 20506051

Slug/SNAI2 Regulates Cell Proliferation and Invasiveness of Metastatic Prostate Cancer Cell Lines

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2010 May 28
PMID 20506051
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Many metastatic cancers recapitulate the epithelial-to-mesenchymal transition (EMT) resulting in enhanced cell motility and invasiveness. The EMT is regulated by several transcription factors, including the zinc finger protein SNAI2, also named Slug, which appears to exert additional functions during development and cancer progression. We have studied the function of SNAI2 in prostate cancer cells. Quantitative RT-PCR analysis showed strong SNAI2 expression particularly in the PC-3 and PC3-16 prostate carcinoma cell lines. Knockdown of SNAI2 by specific siRNA induced changes in EMT markers and inhibited invasion of both cell lines into a matrigel matrix. SNAI2 siRNA-treated cells did not tolerate detachment from the culture plates, likely at least in part due to downregulation of integrin alpha6beta4. SNAI2 knockdown disturbed the microtubular and actin cytoskeletons, especially severely in PC-3 cells, resulting in grossly enlarged, flattened, and sometimes multinuclear cells. Knockdown also decreased cell proliferation, with a prominent G0/G1 arrest in PC3-16. Together, our data imply that SNAI2 exerts strong effects on the cytoskeleton and adhesion of those prostate cancer cells that express it and is necessary for their proliferation and invasiveness.

Citing Articles

A Novel Interaction of Slug (SNAI2) and Nuclear Actin.

Zhuo L, Stockl J, Frohlich T, Moser S, Vollmar A, Zahler S Cells. 2024; 13(8.

PMID: 38667311 PMC: 11049500. DOI: 10.3390/cells13080696.


isolated from giant panda can attenuate dextran sodium sulfate-induced colitis in mice.

Yu S, Xie J, Guo Q, Yan X, Wang Y, Leng T Front Microbiol. 2024; 15:1361945.

PMID: 38646621 PMC: 11027743. DOI: 10.3389/fmicb.2024.1361945.


Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer.

Zhang M, Ceyhan Y, Mei S, Hirz T, Sykes D, Agoulnik I Cancers (Basel). 2023; 15(22).

PMID: 38001678 PMC: 10670027. DOI: 10.3390/cancers15225418.


Expression of epithelial-mesenchymal transition-associated proteins and proliferating cell nuclear antigen in dihydropyridine-induced gingival overgrowth fibroblasts: A preliminary study.

Chen P, Chuang Y, Huang C, Lu H J Dent Sci. 2023; 18(2):551-559.

PMID: 37021214 PMC: 10068551. DOI: 10.1016/j.jds.2022.08.025.


Combinatorial effects of telmisartan and docetaxel on cell viability and metastatic gene expression in human prostate and breast cancer cells.

Khorsand M, Mostafavi-Pour Z, Razban V, Khajeh S, Zare R Mol Biol Res Commun. 2022; 11(1):11-20.

PMID: 35463822 PMC: 9012430. DOI: 10.22099/mbrc.2022.42638.1700.


References
1.
Turner F, Broad S, Khanim F, Jeanes A, Talma S, Hughes S . Slug regulates integrin expression and cell proliferation in human epidermal keratinocytes. J Biol Chem. 2006; 281(30):21321-21331. DOI: 10.1074/jbc.M509731200. View

2.
Janssen K, Pohlmann S, Janicke R, Schulze-Osthoff K, Fischer U . Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment. Blood. 2007; 110(10):3662-72. DOI: 10.1182/blood-2007-02-073213. View

3.
Wlazlinski A, Engers R, Hoffmann M, Hader C, Jung V, Muller M . Downregulation of several fibulin genes in prostate cancer. Prostate. 2007; 67(16):1770-80. DOI: 10.1002/pros.20667. View

4.
Alves C, Carneiro F, Hoefler H, Becker K . Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front Biosci (Landmark Ed). 2009; 14(8):3035-50. DOI: 10.2741/3433. View

5.
Jafarnejad S, Mowla S, Matin M . Knocking-down the expression of nucleostemin significantly decreases rate of proliferation of rat bone marrow stromal stem cells in an apparently p53-independent manner. Cell Prolif. 2008; 41(1):28-35. PMC: 6496312. DOI: 10.1111/j.1365-2184.2007.00505.x. View